Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Charles Schwab
SCHW
|
+$692M |
| 2 |
Qiagen
QGEN
|
+$623M |
| 3 |
Autodesk
ADSK
|
+$477M |
| 4 |
Lam Research
LRCX
|
+$381M |
| 5 |
Match Group
MTCH
|
+$358M |
Top Sells
| 1 |
TSMC
TSM
|
+$545M |
| 2 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$421M |
| 3 |
Illumina
ILMN
|
+$408M |
| 4 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$400M |
| 5 |
Fidelity National Information Services
FIS
|
+$389M |
Sector Composition
| 1 | Technology | 22.25% |
| 2 | Financials | 17.64% |
| 3 | Healthcare | 15.25% |
| 4 | Industrials | 13.09% |
| 5 | Communication Services | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOME
801
DELISTED
At Home Group Inc.
HOME
| $907K | ﹤0.01% |
58,688
-590
| -1% | -$9.12K |
|
|
XLNX
802
DELISTED
Xilinx Inc
XLNX
| $891K | ﹤0.01% |
6,285
+1,812
| +41% | +$257K |
|
803
Banco Macro
BMA
$2.82B
| $866K | ﹤0.01% |
55,645
-7,822
| -12% | -$122K |
|
804
Arrow Electronics
ARW
$6.5B
| $861K | ﹤0.01% |
8,852
-381
| -4% | -$37.1K |
|
|
CBAY
805
DELISTED
Cymabay Therapeutics
CBAY
| $846K | ﹤0.01% |
+147,353
| New | +$846K |
|
806
Kinross Gold
KGC
$27.3B
| $840K | ﹤0.01% |
+114,505
| New | +$840K |
|
807
AnaptysBio
ANAB
$619M
| $826K | ﹤0.01% |
38,400
-384
| -1% | -$8.26K |
|
808
ATN International
ATNI
$240M
| $819K | ﹤0.01% |
19,612
-198
| -1% | -$8.27K |
|
809
Open Text
OTEX
$8.7B
| $812K | ﹤0.01% |
17,855
+3,242
| +22% | +$147K |
|
|
CALA
810
DELISTED
Calithera Biosciences, Inc
CALA
| $808K | ﹤0.01% |
8,231
-82
| -1% | -$8.05K |
|
811
Voyager Therapeutics
VYGR
$222M
| $805K | ﹤0.01% |
112,583
-1,129
| -1% | -$8.07K |
|
812
Mersana Therapeutics
MRSN
$38.2M
| $791K | ﹤0.01% |
1,189
-2,006
| -63% | -$1.33M |
|
813
Levi Strauss
LEVI
$8.59B
| $779K | ﹤0.01% |
38,809
-390
| -1% | -$7.83K |
|
|
CVET
814
DELISTED
Covetrus, Inc. Common Stock
CVET
| $772K | ﹤0.01% |
+26,870
| New | +$772K |
|
815
Sealed Air
SEE
$4.91B
| $762K | ﹤0.01% |
+16,634
| New | +$762K |
|
816
Varex Imaging
VREX
$481M
| $753K | ﹤0.01% |
45,143
-453
| -1% | -$7.56K |
|
817
Steel Dynamics
STLD
$19.2B
| $748K | ﹤0.01% |
+20,284
| New | +$748K |
|
818
MillerKnoll
MLKN
$1.4B
| $734K | ﹤0.01% |
+21,706
| New | +$734K |
|
819
B2Gold
BTG
$5.6B
| $723K | ﹤0.01% |
129,083
-5,379
| -4% | -$30.1K |
|
|
TBIO
820
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $705K | ﹤0.01% |
38,263
-384
| -1% | -$7.08K |
|
|
TCRR
821
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $697K | ﹤0.01% |
22,527
-228
| -1% | -$7.05K |
|
|
CLVS
822
DELISTED
Clovis Oncology, Inc.
CLVS
| $691K | ﹤0.01% |
143,903
-1,444
| -1% | -$6.93K |
|
823
Workday
WDAY
$61.6B
| $689K | ﹤0.01% |
2,877
+887
| +45% | +$212K |
|
824
Seres Therapeutics
MCRB
$163M
| $683K | ﹤0.01% |
+1,394
| New | +$683K |
|
825
James River Group
JRVR
$242M
| $680K | ﹤0.01% |
+13,830
| New | +$680K |
|